Samsara Bio Capital, LLC Scholar Rock Holding Corp Transaction History
Samsara Bio Capital, LLC
- $173 Million
- Q3 2024
A detailed history of Samsara Bio Capital, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 6,788,609 shares of SRRK stock, worth $274 Million. This represents 31.52% of its overall portfolio holdings.
Number of Shares
6,788,609
Previous 6,788,609
-0.0%
Holding current value
$274 Million
Previous $56.5 Million
3.84%
% of portfolio
31.52%
Previous 29.08%
Shares
4 transactions
Others Institutions Holding SRRK
# of Institutions
187Shares Held
74.8MCall Options Held
589KPut Options Held
866K-
Siren, L.L.C. New York, NY11.3MShares$455 Million4.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.65MShares$349 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$229 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.24MShares$212 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.03MShares$163 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $2.09B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...